The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2025Identifying Protein Changes Associated with Parkinson’s Disease: Proteomics Public Data Compilation
Study Rationale: Accumulation of toxic protein aggregates is a hallmark of neurodegenerative disorders that include Parkinson’s disease (PD), Lewy body dementia (LBD) and multiple system atrophy (MSA)...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2025Identifying Biochemical, Histological and Molecular Signatures of Constipation Associated with Parkinson’s Disease
Study Rationale: Constipation is one of the most common non-motor symptoms of Parkinson’s disease (PD). It occurs in 50 to 80 percent of people with PD and doubles the risk of PD diagnosis after 10...
-
Research Grant, 2025Discovery of Alpha-synuclein PET Tracer for Parkinson’s Disease
Study Rationale: In Parkinson’s disease (PD), a protein called alpha-synuclein builds up inside of brain cells. Research suggests that this protein accumulation damages the cells and eventually leads...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2025Elucidating the Role of PINK1 and PRKN in Cell Type-specific Responses to Alpha-synuclein Pathology
Study Rationale: Parkinson’s disease (PD) is associated with loss of dopamine neurons and aggregation of the protein alpha-synuclein. Mutations that impair the function of PINK1 and PRKN, proteins...
-
iPSC Phenotyping Environmental Exposure Program, 2025Screening the Functional Impact of Environmental Chemicals on Human Neurons and Astrocytes in Culture
Study Rationale: With growing global concerns about environmental chemicals acting as a trigger of Parkinson's disease (PD), we will assess the affect such molecules have on the electrical activity...
-
Neuronal Synuclein Disease Endotypes 2024, 2025Characterizing Molecular Subtypes in Parkinson’s Disease and Lewy Body Dementia
Study Rationale: There is currently no disease-modifying treatment for Parkinson’s disease (PD) or Lewy body dementia (LBD). One possible reason is that both of these disorders are highly...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.